Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-23

Clinical Trial Update: Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms. [NA]

View source ↗

Summary

This clinical trial update describes evaluation of intragen fractional radiofrequency with the NeuViVa system for vaginal laxity and urogynecology symptoms, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intragen Fractional Radiofrequency with NeuViVa

Snippet

Sponsor: SHERRY Thomas | Conditions: Vaginal Laxity, Urinary Incontinence | NA | Status: UNKNOWN